
TeamSTEPPS Master Trainer
Education:University of Rochester, Rochester, New York
- Ph.D., Health Services Research and Policy
- Master of Science, Public Policy Analysis
- Master of Public Health
Duke University, Durham, North Carolina
- B.A., cum laude
Jill Lavigne, Ph.D., MPH, is a professor of pharmacy and teaches FDA Real World Data and Evidence, pharmacoeconomics, informatics, healthcare quality improvement, and managed care. Her research in pharmacoepidemiology and drug safety has appeared in journals including JAMA Psychiatry and has been cited by other published research more than 1,000 times. She is an economist on the New York State Medicaid Drug Utilization Review Board and co-facilitator for the Rochester Day of Quality. Dr Lavigne has served campus governance through campus committees on strategic planning, rank and tenure, grievance, faculty assembly, and faculty welfare. Dr. Lavigne holds a Ph.D. in health services research, an M.S. in public policy analysis, and an MPH from the University of Rochester. She holds a B.A. from Duke University where she studied Chinese and East Asian policy.
Publications
Full List of Publications on Google Scholar
- Pigeon Response to Kawada regarding Comparative safety of insomnia medications and deaths by suicide among veterans, Sleep Medicine. In press. Co-authored with K. Hur and J.B. Gibbons.
- Pigeon Associations between insomnia medications and risk of death by suicide, Sleep Med, Nov. 2023, 199-206. Co-authored with K. Hur and J.B. Gibbons.
- Rural community pharmacists’ perspectives on lethal means management, Clinical Gerontologist, Aug. 2023, 1-13. Co-authored with J. West and D. Carpenter.
- Folic Acid Prescription and Suicide Attempt Prevention: Effect of Past Suicidal Behavior, Psychiatric Diagnosis and Psychotropic Medication, BMJ Psychiatry Open, Aug. 2023. Co-authored with J.J. Mann, K. Hur, R. D. Gibbons.
- Impact of a brief suicide prevention training with an interactive video case, American Journal of Pharmaceutical Education, July 2023. Co-authored with D.M. Carpenter, A. Stover, S. Harris, and H. Anksorus.
- Development of the Pharm-SAVES educational module for gatekeeper suicide prevention training for community pharmacy staff, Health Expectations, June 2023. Co-authored with A.N. Stover and D. Carpenter.
- The association between vitamin D serum levels, supplementation, and suicide attempts and intentional self-harm in veterans, PLoS ONE 2023. Co-authored with J.B. Gibbons.
- Benztropine and suicide attempts and intentional self-harm, Psychiatry Research, 2023. Co-authored with R.D. Gibbons, K. Hur, and J.J. Mann.
- The Association between Vitamin D Supplementation and Infection with COVID-19 in Veterans, Sci Rep, 2022. Co-authored with J.B. Gibbons, E.C. Norton, J.S. McCullough, D.O. Meltzer, V. Fiedler, and R.D. Gibbons.
- Association Between Folic Acid Prescription Fills and Suicide Attempts and Intentional Self-harm Among Privately Insured US Adults, JAMA Psychiatry, Nov. 2022. Co-authored with R.D. Gibbons, K. Hur, and J.J. Mann.
- A scoping review of suicide prevention training programs for pharmacists and student pharmacists, Am J Pharm Educ, Jan. 2022. Co-authored with A.N. Stover and D.M. Carpenter.
- Developing and evaluating a module to teach suicide prevention communication skills to student pharmacists, Currents in Pharmacy Teaching and Learning, Volume 14, Issue 4, 449-456.Co-authored with N. Pothireddy N, A.S. Groman, and D.M. Carpenter.
- Teaching Implicit Bias and Its Management in the Pain Care of Sickle Cell Anemia Patients in a Hyflex Pre-Professional Classroom During COVID-19, Pain Med, March 2022. Co-authored with A. Groman and M. Price.